Clinical profile and outcome of cardiac amyloidosis in a Spanish referral center
Tài liệu tham khảo
García-Pavía, 2011, Amiloidosis. También una enfermedad del corazón, Rev Esp Cardiol, 64, 797, 10.1016/j.recesp.2011.05.003
Gonzalez-Lopez, 2017, Diagnosis and Treatment of Transthyretin Cardiac Amyloidosis. Progress and Hope, Rev Esp Cardiol., 70, 991, 10.1016/j.recesp.2017.05.018
Rapezzi, 2015, Cardiac amyloidosis: the great pretender, Heart Fail Rev., 20, 117, 10.1007/s10741-015-9480-0
Perugini, 2005, Noninvasive etiologic diagnosis of cardiac amyloidosis using 99mTc-3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy, J Am Coll Cardiol., 46, 1076, 10.1016/j.jacc.2005.05.073
Maurer, 2017, Addressing common questions encountered in the diagnosis and management of cardiac amyloidosis, Circulation., 135, 1357, 10.1161/CIRCULATIONAHA.116.024438
Lousada, 2015, Light chain amyloidosis: patient experience survey from the Amyloidosis Research Consortium, Adv Ther., 32, 920, 10.1007/s12325-015-0250-0
Adams, 2018, Patisiran, an RNAi therapeutic, for hereditary transthyretin amyloidosis, N Engl J Med., 379, 11, 10.1056/NEJMoa1716153
Sayago, 2016, Analysis of diagnostic and therapeutic strategies in advanced cardiac light-chain amyloidosis, J Hear Lung Transplant., 35, 1
Benson, 2018, Inotersen treatment for patients with hereditary transthyretin amyloidosis, N Engl J Med., 379, 22, 10.1056/NEJMoa1716793
Merlini, 2017, AL amyloidosis: from molecular mechanisms to targeted therapies, Hematol Am Soc Hematol Educ Progr., 2017, 1, 10.1182/asheducation-2017.1.1
Maurer, 2018, Tafamidis treatment for patients with transthyretin amyloid cardiomyopathy, N Engl J Med., 379, 1007, 10.1056/NEJMoa1805689
Falk, 2005, Diagnosis and management of the cardiac amyloidoses, Circulation., 112, 2047, 10.1161/CIRCULATIONAHA.104.489187
Gillmore, 2016, Nonbiopsy diagnosis of cardiac transthyretin amyloidosis, Circulation., 133, 2404, 10.1161/CIRCULATIONAHA.116.021612
Rajkumar, 2014, International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma, Lancet Oncol, 15, e538, 10.1016/S1470-2045(14)70442-5
Ruberg, 2019, Transthyretin amyloid cardiomyopathy: JACC state-of-the-art review, J Am Coll Cardiol., 73, 2872, 10.1016/j.jacc.2019.04.003
Rapezzi, 2009, Systemic cardiac amyloidoses: Disease profiles and clinical courses of the 3 main types, Circulation., 120, 1203, 10.1161/CIRCULATIONAHA.108.843334
Wechalekar, 2016, Systemic amyloidosis, Lancet., 387, 2641, 10.1016/S0140-6736(15)01274-X
Krsnik, 2015, Light chain amyloidosis: Experience in a tertiary hospital: 2005-2013, Rev Clin Esp., 215, 1, 10.1016/j.rce.2014.08.013
Gallego-Delgado, 2016, Extracellular volume detects amyloidotic cardiomyopathy and correlates with neurological impairment in transthyretin-familial amyloidosis, Rev Esp Cardiol., 69, 923, 10.1016/j.recesp.2016.02.032
López-Sainz, 2019, Prevalence of cardiac amyloidosis among elderly patients with systolic heart failure or conduction disorders, Amyloid., 26, 156, 10.1080/13506129.2019.1625322
Zegri-Reiriz, 2019, Prevalence of cardiac amyloidosis in patients with carpal tunnel syndrome, J Cardiovasc Transl Med., 12, 507, 10.1007/s12265-019-09895-0
Gonzalez-Lopez, 2015, Wild-type transthyretin amyloidosis as a cause of heart failure with preserved ejection fraction, Eur Heart J., 36, 2585, 10.1093/eurheartj/ehv338
Gonzalez-Lopez, 2017, Clinical characteristics of wild-type transthyretin cardiac amyloidosis: disproving myths, Eur Heart J., 38, 1895, 10.1093/eurheartj/ehx043
García-Pavía, 2011, Abordaje familiar en la amiloidosis cardiaca hereditaria por transtiretina, Rev Esp Cardiol., 64, 523, 10.1016/j.recesp.2010.10.018
Gomez-Bueno, 2009, Cardiac amyloidosis: the importance of a multidisciplinary approach, Rev Esp Cardiol., 62, 698, 10.1016/S0300-8932(09)71339-9
Martinez-Naharro, 2017, Magnetic resonance in transthyretin cardiac amyloidosis, J Am Coll Cardiol., 70, 466, 10.1016/j.jacc.2017.05.053
Rowczenio, 2019, Analysis of the TTR gene in the investigation of amyloidosis: A 25-year single UK center experience, Hum Mutat., 40, 90, 10.1002/humu.23669